Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bedrocan Cannabis Corp. V.BED

Healthcare Biotechnology


TSXV:BED - Post by User

Bedrocan Cannabis Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Canny321on Oct 06, 2014 11:48pm
212 Views
Post# 23004738

Exciting times ahead the elite train

Exciting times ahead the elite train Bedrocan is a classy solid honest and genuine operational team. The validation from patients and doctors is what will drive sales and bottom line to define the share price. If you put a survey out on which CEOs know what re: cannabis - most would say promotion, Marc Wayne would say helping patients while buying value.

https://www.stockhouse.com/news/newswire/2014/10/06/the-bedrocan-v-bed-strategy-consistency-product-price-and-supply
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities